title: Pooled human immunoglobulin therapy in critically Ill patients with pandemic 2009 influenza A(H1N1) pneumonitis and immunoglobulin G2 subclass (IgG2) deficiency.
authors.forename: Claire L
authors.initials: CL
authors.lastname: Gordon
authors.forename: Kath
authors.initials: K
authors.lastname: Langan
authors.forename: Patrick G P
authors.initials: PG
authors.lastname: Charles
authors.forename: Rinaldo
authors.initials: R
authors.lastname: Bellomo
authors.forename: Graeme K
authors.initials: GK
authors.lastname: Hart
authors.forename: Joseph
authors.initials: J
authors.lastname: Torresi
authors.forename: Paul D R
authors.initials: PD
authors.lastname: Johnson
authors.forename: M Lindsay
authors.initials: ML
authors.lastname: Grayson
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D017074:Common Variable Immunodeficiency / Q000150:complications*; D016638:Critical Illness; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D053118:Influenza A Virus, H1N1 Subtype / Q000302:isolation & purification*; D007251:Influenza, Human / Q000150:complications* / Q000821:virology; D008297:Male; D011014:Pneumonia / Q000188:drug therapy*; D011247:Pregnancy; D016879:Salvage Therapy / Q000379:methods*; D016896:Treatment Outcome; D053243:Zanamivir
chemical_list: D000998:Antiviral Agents; D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous; D053243:Zanamivir